Cited by 1,095Neurofibromatosis and Schwannoma CasesProtein Tyrosine PhosphatasesProtein Kinase Regulation and GTPase Signaling

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

The neurofibromatosis type 1 gene encodes a protein related to GAP

Xu, Gangfeng, O'Connell, Peter, Viskochil, David, Cawthon, Richard, Robertson, Margaret, Culver, Melanie, Dunn, Diane, Stevens, Jeff, Gesteland, Ray, White, Ray, Weiss, Robert·1990·Cell

DOI 10.1016/0092-8674(90)90024-9

Open this paper in CoChat — free account

Abstract

cDNA walking and sequencing have extended the open reading frame for the neurofibromatosis type 1 gene (NF1). The new sequence now predicts 2485 amino acids of the NF1 peptide. A 360 residue region of the new peptide shows significant similarity to the known catalytic domains of both human and bovine GAP (GTPase activating protein). A much broader region, centered around this same 360 amino acid sequence, is strikingly similar to the yeast IRA1 product, which has a similar amino acid sequence and functional homology to mammalian GAP. This evidence suggests that NF1 encodes a cytoplasmic GAP-like protein that may be involved in the control of cell growth by interacting with proteins such as the RAS gene product. Mapping of the cDNA clones has confirmed that NF1 spans a t(1;17) translocation mutation and that three active genes lie within an intron of NF1, but in opposite orientation.

Integrity signals

Registry

Crossref · 10.1016/0092-8674(90)90024-9

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,512
A simple method for displaying the hydropathic character of a protein
Kyte, J., & Doolittle, R. F. (1982) · Journal of Molecular Biology · doi:10.1016/0022-2836(82)90515-0 · Cited by 22,927
A comprehensive set of sequence analysis programs for the VAX
Devereux, J., Haeberli, P. E., & Smithies, O. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.387 · Cited by 14,222
Improved tools for biological sequence comparison.
Pearson, W. R., & Lipman, D. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2444 · Cited by 11,227
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
(1984) · Analytical Biochemistry · doi:10.1016/0003-2697(84)90381-6 · Cited by 4,952
Screening λgt Recombinant Clones by Hybridization to Single Plaques in Situ
Benton, W. D., & Davis, R. W. (1977) · Science · doi:10.1126/science.322279 · Cited by 4,520
Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs
Kozak, M. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.2.857 · Cited by 3,259
[5] Rapid and sensitive sequence comparison with FASTP and FASTA
Pearson, W. R. (1990) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(90)83007-v · Cited by 1,934
Type 1 Neurofibromatosis Gene: Identification of a Large Transcript Disrupted in Three NF1 Patients
Wallace, M. R., Marchuk, D. A., Andersen, L. B., Letcher, R., Odeh, H. M., Saulino, A. M., Fountain, J. W., Brereton, A., Nicholson, J. M., Mitchell, A. L., et al. (1990) · Science · doi:10.1126/science.2134734 · Cited by 1,478

Show all 42 references

Research works printed but not linked: 1

Stumpf, 1987, Neurofibromatosis, Arch. Neurol., 45, 575

Sorted by citations

Items 701–800 of 1,000

Focal segmental glomerulosclerosis in association with neurofibromatosis type 1: a case report and proposed molecular pathways
Afshinnia, F., Vega-Warner, V., & Killen, P. (2013) · Clinical Kidney Journal · doi:10.1093/ckj/sft010 · Cited by 12
“The p21-ras protein binds to guanine nucleotides, possesses intrinsic GTPase activity and functions as an important regulator of cell growth [15, 16].”
Background
Immunoexpression of neurofibromin, S-100 protein, and leu-7 and mutation analysis of the NF1 gene at codon 1423 in osteofibrous dysplasia
Sakamoto, A., Oda, Y., Oshiro, Y., Tamiya, S., Iwamoto, Y., & Tsuneyoshi, M. (2001) · Human Pathology · doi:10.1053/hupa.2001.28954 · Cited by 12
Functional Analysis of Mutations in Exon 9 of NF1 Reveals the Presence of Several Elements Regulating Splicing
Hernández-Imaz, E., Martín, Y., Conti, L. D., Melean, G., Valero, A., Baralle, M., & Hernández-Chico, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141735 · Cited by 12
Chemical Carcinogenesis in Fishes
Rotchell, J. M., Miller, M., Hinton, D. E., Giulio, R. T. D., & Ostrander, G. K. (2008) · CRC Press eBooks · doi:10.1201/9780203647295.ch12 · Cited by 12
RNA Interference, Editing, and Modification
(2004) · Humana Press eBooks · doi:10.1385/1592597750 · Cited by 12
The Ras Signalling Pathway as a Target in Cancer Therapy
Graham, K., & Olson, M. F. (2007) · Springer eBooks · doi:10.1007/978-3-540-31209-3_8 · Cited by 12
Different functions of Smg GDP dissociation stimulator and mammalian counterpart of yeast Cdc25.
Nakanishi, H., Kaibuchi, K., Orita, S., Ueno, N., & Takai, Y. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36577-8 · Cited by 12
Genetics of Neurofibromatosis 1-Associated Peripheral Nerve Sheath Tumors
Stephens, K. G. (2003) · Cancer Investigation · doi:10.1081/cnv-120025093 · Cited by 12
“One functional domain of neurofibromin has been defined, the GAP-related domain (GRD), so called because of its structural and functional homology to mammalian p120-GAP (GTPase activating protein) and yeast genes known to regulate the Ras pathway.([24,25]) The Ras-GAP proteins function as negative regulators of Ras by…”
Background
Three novel mutations of the NF1 gene detected by temperature gradient gel electrophoresis of exons 5 and 8
Horn, D., Robinson, P. N., Böddrich, A., Buske, A., Tinschert, S., & Nürnberg, P. (1996) · Electrophoresis · doi:10.1002/elps.1150171011 · Cited by 12
A Pituitary Specific Point Mutation of Codon 201 of the Gs.ALPHA. Gene in a Pituitary Adenoma of a Patient with Multiple Endocrine Neoplasia(MEN) Type 1.
HOSOI, E., Yokogoshi, Y., Hosoi, E., Yokoi, K., Sano, T., & Saito, S. (1992) · Endocrinologia Japonica · doi:10.1507/endocrj1954.39.319 · Cited by 12
“Recently, in some hereditary tumors including retinoblastoma, Wilms' tumor, familial adenomatous polyposis, and neurofibromatosis, the discovery of a defect at a specific chromosomal loci resulted in the cloning of a gene which is inactivated during tumor development [1-4].”
Background
Biological actions of oncogenes
Smith, M. R., Matthews, N. T., Jones, K. A., & Kung, H. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90050-n · Cited by 13
A deletion in the 5 ′-region of the neurofibromatosis type 1 (NF1) gene
Hoffmeyer, S., Assum, G., Kaufmann, D., Schwenk, K., & Krone, W. (1994) · Human Genetics · doi:10.1007/bf02272852 · Cited by 12
GTP binding proteins and growth factor signal transduction
Ives, H. E. (1991) · Cellular Signalling · doi:10.1016/0898-6568(91)90026-q · Cited by 12
Rapid response genes as markers of cellular signaling during cortical histogenesis: Their potential in understanding mental retardation
Kaufmann, W. E., Yamagata, K., Andreasson, K. I., & Worley, P. F. (1994) · International Journal of Developmental Neuroscience · doi:10.1016/0736-5748(94)90073-6 · Cited by 12
Recent Advances in the Development of Anticancer Drugs that Act against Signalling Pathways
Powis, G. (1994) · Tumori Journal · doi:10.1177/030089169408000201 · Cited by 12
Interactions between Ras and Rap signaling pathways during neurodevelopment in health and disease
Cherra, S. J., & Lamb, R. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1352731 · Cited by 11
Pathogenic noncoding variants in the neurofibromatosis and schwannomatosis predisposition genes
Perez‐Becerril, C., Evans, D. G., & Smith, M. J. (2021) · Human Mutation · doi:10.1002/humu.24261 · Cited by 13
“Regions of high homology with other members of GTPase activating protein (GAP) family exist between exons 21 and 27a (Y. Li et al., 1995; G. F. Xu et al., 1990).”
Background
High-grade primary diffuse leptomeningeal gliomatosis in a child with neurofibromatosis Type 1
King, J. A. J., HALLIDAY, W. C., & Drake, J. M. (2008) · Journal of Neurosurgery Pediatrics · doi:10.3171/ped.2008.2.12.402 · Cited by 11
Phenotypic characterization of transgenic mice harboring Nf1+/− or Nf1−/− osteoclasts in otherwise Nf1+/+ background
Alanne, M. H., Siljamäki, E., Peltonen, S. A., Väänänen, K., Windle, J. J., Parada, L. F., Määttä, J. A., & Peltonen, J. T. K. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24088 · Cited by 12
“The NF1 gene product, neurofibromin, accelerates the hydrolysis of active Ras-GTP to inactive Ras-GDP thus regulating cell proliferation and differentiation [Xu et al., 1990].”
Background
An Intracranial Leiomyosarcoma in a Child with Neurofibromatosis Type 1
Jhas, S., Henriques, L., Hawkins, C. E., Bouffet, É., & Rutka, J. T. (2009) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s031716710000785x · Cited by 11
Inhibition of Ras/Raf Interaction by Anti-oncogenic Mutants of Neurofibromin, the Neurofibromatosis Type 1 (NF1) Gene Product, in Cell-free Systems
Mori, S., Satoh, T., Koide, H., Nakafuku, M., Villafranca, E., & Kaziro, Y. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.48.28834 · Cited by 11
Neurofibromatosis: Novel and Recurrent Mutations in Turkish Patients
Terzi, Y. K., Balcı, S. O., Anlar, B., Aysun, S., & Ayter, Ş. (2007) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2007.07.005 · Cited by 11
Mutational analysis of N-RAS and GAP-related domain of the neurofibromatosis type 1 gene in chronic myelogenous leukemia
Garicochea, B., Giorgi, R. R., Filho, V. O., Dorlhiac‐Llacer, P. E., & Bendit, I. (1998) · Leukemia Research · doi:10.1016/s0145-2126(98)00076-9 · Cited by 11
N-ras Mutations in Acute Myelogenous Leukemia: A Review of the Current Literature and an update of the Southwest Oncology Group Experience
Radich, J. P., Kopecky, K. J., Appelbaum, F. R., Willman, C. L., & Collins, S. (1992) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199209053564 · Cited by 11
Tumor suppressor genes in molecular medicine
Hoppe‐Seyler, F., & Butz, K. (1994) · Journal of Molecular Medicine · doi:10.1007/bf00227456 · Cited by 11
“The NF1 gene product, neurofibromin, contains a high degree of amino acid homologies to GTPase-activating proteins [148].”
Background
Single-cell PCR performed with neurofibroma Schwann cells reveals the presence of both alleles of the neurofibromatosis type 1 (NF1) gene
Stark, M., Assum, G., & Krone, W. (1995) · Human Genetics · doi:10.1007/bf00197423 · Cited by 11
“Krone ([Y:~) Abteilung Humangenetik, Universitit Ulm, Albert-Einstein-Allee 11, D-89070 Ulm, Germany shown to belong to the family of GTPase-activating proteins (GAP) on the basis of the structural and functional homology of a central domain ("GRD", GAP-related domain) to similar sequences within p l20GAP and other pr…”
Background
Application of Signal Transduction Inhibition as a Therapeutic Strategy for Central Nervous System Tumors
Pollack, I. F., Bredel, M., & Erff, M. (1998) · Pediatric Neurosurgery · doi:10.1159/000028729 · Cited by 11
Candidate genes for multiple endocrine neoplasia type 1
Lagercrantz, J., Larsson, C., Grimmond, S. M., Skogseid, B. M., Gobl, A., Friedman, E., Carson, E., Phelan, C., Öberg, K., Nordenskjöld, M., et al. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb00930.x · Cited by 11
Targeted NF1 cancer therapeutics with multiple modes of action: small molecule hormone-like agents resembling the natural anticancer metabolite, 2-methoxyoestradiol
Shen, Y.-C., Upadhyayula, R., Cevallos, S. A., Messick, R. J., Hsia, T., Leese, M. P., Jewett, D. M., Ferrer-Torres, D., Roth, T. M., Döhle, W., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.345 · Cited by 10
“…type I (NF1) is an autosomal dominant disorder associated with loss-of-function mutations in the NF1 tumour suppressor gene that encodes the multi-functional protein Neurofibromin (Wallace et al, 1990; Xu et al, 1990; Roth et al, 2008a; Gottfried et al, 2010).”
Background
Blockade of Serotonin 5-HT6 Receptor Constitutive Activity Alleviates Cognitive Deficits in a Preclinical Model of Neurofibromatosis Type 1
Doucet, E., Grychowska, K., Zajdel, P., Bockaert, J., Marin, P., & Bécamel, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810178 · Cited by 10
The RASopathies: Biology, genetics and therapeutic options
Longo, J. F., & Carroll, S. L. (2022) · Advances in cancer research · doi:10.1016/bs.acr.2021.07.007 · Cited by 10
The contribution of morbidity and unemployment for the reduced labor market participation of individuals with neurofibromatosis 1 in Finland
Kallionpää, R. A., Johansson, E., Böckerman, P., Peltonen, J. T. K., & Peltonen, S. A. (2023) · European Journal of Human Genetics · doi:10.1038/s41431-023-01426-5 · Cited by 10
Determination of Ras-GTP and Ras-GDP in patients with acute myelogenous leukemia (AML), myeloproliferative syndrome (MPS), juvenile myelomonocytic leukemia (JMML), acute lymphocytic leukemia (ALL), and malignant lymphoma: assessment of mutational and indirect activation
Raepple, D., von Lintig, F. C., Żemojtel, T., Duchniewicz, M., Jung, A., Lübbert, M., Boss, G. R., & Scheele, J. S. (2008) · Annals of Hematology · doi:10.1007/s00277-008-0593-6 · Cited by 10
“These include the Ras-GAP NF-1, which is mutatedintheautosomal dominantformofneurofibromatosis type 1 [ 16 , 17].”
Background
Fatal malignant melanoma in a child with neurofibromatosis type 1
Binamer, Y., & Al‐Khenaizan, S. (2007) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2007.03205.x · Cited by 10
Abnormalities of the p53 gene in juvenile myelomonocytic leukaemia
Miyauchi, J., Asada, M., Tsunematsu, Y., Kaneko, Y., Kojima, S., & Mizutani, S. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01634.x · Cited by 10
“…tumour suppressor gene whose protein product has GTPase-activating protein activity and inactivates GTP-bound (active) form of ras family proteins (Xu et al, 1990; Boguski & McCormick, 1993), have been shown to be present in a substantial proportion of patients with JMML (Shannon et al, 1994;…”
Background
A nonsense mutation at Arg-1947 in the NF1 gene in a case of neurofibromatosis type 1 in a Korean patient
Park, K. C., Choi, H. O., Park, K. H., Kim, K. H., & Eun, H. C. (2000) · Journal of Human Genetics · doi:10.1007/s100380050016 · Cited by 10
“Neurofibromin can downregulate p21-Ras-GTP through its highly conserved, central GAP-related domain (GRD) (McCormick 1989).”
Background
Surgical Considerations for the Familial Cancer Syndrome, Neurofibromatosis 1: A Comprehensive Review
Slam, K. D., Bohman, S., Sharma, R., & Chaudhuri, P. K. (2009) · The American Surgeon · doi:10.1177/000313480907500203 · Cited by 10
FAMILIAL NEUROGENIC TUMOR SYNDROMES
Kimmelman, A. C., & Liang, B. C. (2001) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70268-9 · Cited by 10
Analysis of the sequence and embryonic expression of chicken neurofibromin mRNA
Schafer, G. L., Ciment, G., Stocker, K. M., & Baizer, L. (1993) · Molecular and Chemical Neuropathology · doi:10.1007/bf03160119 · Cited by 10
“Analysis of the predicted amino acid sequence of the NF1 gene product (Ballester et al., 1990; Xu et al., 1990a ) reveals a 360 amino acid segment marked by a high degree of similarity to the ras-GTPase activator protein, or ras-GAP, which modulates ras-initiated signal transduction pathways (Trahey and McCormick, 198…”
Background
Overexpression of RPI1, a Novel Inhibitor of the Yeast Ras-Cyclic AMP Pathway, Down-Regulates Normal but Not Mutationally Activated Ras Function
Kim, J., & Powers, S. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.8.3894-3904.1991 · Cited by 10
“Nonredundant Ras GAPs may also exist in animal cells, in which two distinct proteins with GAP activity for p2lras have been discovered: cytoplasmic GAP and the NFI gene product (1, 24, 43, 47, 48).”
Background
Tumour suppressors and the regulation of GTP-binding protein activity
Rey, I., & Hall, A. (1993) · Trends in Cell Biology · doi:10.1016/0962-8924(93)90149-u · Cited by 10
The clinical significance of antigen receptor gene rearrangements in lymphoid neoplasia
Sklar, J., & Longtine, J. (1992) · Cancer · doi:10.1002/1097-0142(19920915)70:4+ · Cited by 22
Molecular Genetics of von Recklinghausen Neurofibromatosis
Wallace, M. R., & Collins, F. S. (1991) · Springer eBooks · doi:10.1007/978-1-4684-5958-6_5 · Cited by 10
Epigenetics and survivorship in pediatric brain tumor patients
Bhattacharya, D., Pomeroy, S. L., Krummel, D. P., & Sengupta, S. (2020) · Journal of Neuro-Oncology · doi:10.1007/s11060-020-03535-3 · Cited by 9
Melanoma: Pathogenesis and Targeted Therapy
Fu, Y., Liu, J., Mo, Z., Wang, B., Deng, Y., & Jiang, Y. (2026) · MedComm · doi:10.1002/mco2.70566 · Cited by 11
“The NF1 protein functions as a negative regulator of RAS proteins via its GTPase activity [ 357 ].”
A Novel Medical Treatment of Cushing's Due to Ectopic ACTH in a Patient With Neurofibromatosis Type 1
Bano, G., Mir, F., Beharry, N., Wilson, P., Hodgson, S. V., & Schey, S. (2012) · Intern J Endocrinol Metab · doi:10.5812/ijem.6898 · Cited by 9
Surgery for Peripheral Nerve Sheath Tumours of the Buttocks, Legs and Feet in 90 Patients With Neurofibromatosis Type 1
Friedrich, R. E., & TUZCU, C. T. (2021) · In Vivo · doi:10.21873/invivo.12329 · Cited by 9
Lymphoproliferative malignancies in patients with neurofibromatosis 1
Bergqvist, C., Hémery, F., Jannic, A., Ferkal, S., & Wolkenstein, P. (2021) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-021-01856-8 · Cited by 9
“It is caused by mutations in the NF1 gene on chromosome 17 which encodes neurofibromin, a tumor suppressor protein [3, 4].”
Background
Clinical characteristics and in silico analysis of congenital pseudarthrosis of the tibia combined with neurofibromatosis type 1 caused by a novel NF1 mutation
Xu, J., Zhang, Y., Zhu, K., Li, J., Guan, Y., He, X., Jin, X., Bai, G., & Hu, L. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.991314 · Cited by 12
“The pathogenic mechanism of CPT is not clear yet and the deletion or inactivation of the NF1 gene is considered as an important cause (Xu et al., 1990; Basu et al., 1992; Cichowski and Jacks, 2001; Viskochil, 2002; Brekelmans et al., 2019).”
Background
Hyaluronan in intra‐operative edema of NF1‐associated neurofibromas
Hagel, C., Behrens, T., Prehm, P., Schnabel, C., Glatzel, M., & Friedrich, R. E. (2011) · Neuropathology · doi:10.1111/j.1440-1789.2011.01276.x · Cited by 9
Oncogenes and tumor suppressor genes
Liu, E., & Weissman, B. E. (1993) · Cancer treatment and research · doi:10.1007/978-1-4615-3088-6_1 · Cited by 9
White matter is increased in the brains of adults with neurofibromatosis 1
Wang, S., Friedman, J. M., Suppa, P., Buchert, R., & Mautner, V. (2022) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-022-02273-1 · Cited by 9
Down-regulated Six2 by knockdown of neurofibromin results in apoptosis of metanephric mesenchyme cells in vitro
Zhou, P., Chen, T., Fang, Y., Wang, H., Li, M., Ma, P., He, L., Li, Q., Liu, T., Yang, X., et al. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-1971-0 · Cited by 9
Ruptured Aneurysm of the Mammary Artery in a Patient With Neurofibromatosis Type I
Urso, S., Carballo, J., Greco, E., Pulitani, I., Álvarez, L., Juaristi, A., Larman, M., & Goiti, J. J. (2007) · Journal of Cardiac Surgery · doi:10.1111/j.1540-8191.2007.00396.x · Cited by 9
Tissue-specific alternative splicing of neurofibromatosis 1 (NF1) mRNA
Danglot, G., Teinturier, C., Duverger, A., & Bernheim, A. (1994) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(94)90053-1 · Cited by 9
Synchronous Optic and Pineal Pilocytic Astrocytomas in a Paediatric Patient with Neurofibromatosis Type 1
Ogura, T., Adachi, J.-I., Nishikawa, R., Hirose, T., & Matsutani, M. (2004) · Pediatric Neurosurgery · doi:10.1159/000083744 · Cited by 9
AMPULLARY CARCINOID AND DUODENAL GASTROINTESTINAL STROMAL TUMOR ASSOCIATED WITH VON RECKLINGHAUSEN'S DISEASE
Ikeda, H., Kawamoto, K., Paku, T., YOSHIDA, Y., Ito, T., & Ogasahara, K. (2008) · Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) · doi:10.3919/jjsa.69.1668 · Cited by 9
Genetic Predispositions and Childhood Cancer
Shannon, K. (1998) · Environmental Health Perspectives · doi:10.1289/ehp.98106801 · Cited by 9
The impact of germline mutations on targeted therapy
Smith, S. A., French, T., & Hollingsworth, S. J. (2013) · The Journal of Pathology · doi:10.1002/path.4273 · Cited by 9
“Of the latter, mutations in the Neurofibromin 1 (NF1 ) gene cause neurofibromatosis type 1, a tumour predisposition syndrome that largely affects the nervous system [77].”
Background
Von Recklinghausen's disease associated with malignant peripheral nerve sheath thmor presenting with constipation and urinary retention: a case report and review of the literature.
Karatzoglou, P., Karagiannidis, A., Kountouras, J., Christofiridis, C. V., Karavalaki, M., Zavos, C., Gavalas, E., Patsiaoura, K., & Vougiouklis, N. (2008) · PubMed · Cited by 9
Decayed, missing, and restored teeth in patients with Neurofibromatosis Type 1
Re, F., & Reul, A. (2018) · Journal of Clinical and Experimental Dentistry · doi:10.4317/jced.54561 · Cited by 9
Vessel and Mast Cell Densities in Sporadic and Syndrome-associated Peripheral Nerve Sheath Tumors.
Friedrich, R. E., Naber, U., Glatzel, M., & Hagel, C. (2015) · PubMed · Cited by 9
Recessive oncogenes: Current status
Gao, X., & Honn, K. V. (1995) · Pathology & Oncology Research · doi:10.1007/bf02893578 · Cited by 9
Symptomatic Tumors Affecting the Urinary Tract in Children With Neurofibromatosis
Barone, J. G., Massad, C. A., Parrott, T. S., Broecker, B. H., & Woodard, J. R. (1995) · The Journal of Urology · doi:10.1016/s0022-5347(01)66920-9 · Cited by 9
PCR and Cancer Diagnostics: Detection and Characterization of Single Point Mutations in Oncogenes and Antioncogenes
Perucho, M. (1994) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4612-0257-8_31 · Cited by 9
Inherited cancer genes
White, R. L. (1992) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(05)80321-1 · Cited by 9
Self-citation
Absence of mutation at the GAP-related domain of the neurofibromatosis type 1 gene in sporadic neurofibrosarcomas and other bone and soft tissue sarcomas
Gómez, L., Barrios, C., Andris Kreicbergs, A., Zetterberg, A., ̃a, A. P., & Castresana, J. S. (1995) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(94)00267-f · Cited by 9
Transgenic mice as research tools in neurocarcinogenesis
Rovigatti, U., Afanasyeva, T., Brandner, S., Hainfellner, J. A., Kiess, M., Maddalena, A. S., Malin, G., Rülicke, T., Steinbach, J. P., Weissenberger, J., et al. (1998) · Journal of NeuroVirology · doi:10.3109/13550289809114516 · Cited by 9
“Neuro®bromatosis The Nf-1 gene, whose product is called neuro®bromin, was cloned in 1990 as the susceptibility gene for neuro®bromatosis 1 (Viskochil et al, 1990; Wallace et al, 1990) and subsequently discovered to encode a member of the GTPase activating proteins (GAP) (Xu et al, 1990).”
Background
ras and Signal Transduction during Sexual Differentiation in the Fission Yeast Schizosaccharomyces pombe
HUGHES, D. A., & Yamamoto, M. P. (1993) · Elsevier eBooks · doi:10.1016/b978-0-12-429350-2.50010-3 · Cited by 9
Ras-Mediated Deregulation of Gene Expression and Contribution to Oncogenesis
Murphy, G. A., & Der, C. J. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-313-2_5 · Cited by 9
The Contribution of Oxidative Stress to NF1-Altered Tumors
Kuhn, E., Natacci, F., Corbo, M., Pisani, L., Ferrero, S., Bulfamante, G., & Gambini, D. (2023) · Antioxidants · doi:10.3390/antiox12081557 · Cited by 10
“Specifically, central exons between 20 and 27a encode the GAP-related domain that stimulates GTPase, which in turn hydrolyzes GTP bound to Ras, converting Ras-GTP to Ras-GDP, its inactivated form [59].”
Background
Noninvasive treatment of cutaneous neurofibromas (cNFs): Results of a randomized prospective, direct comparison of four methods
Richey, P. M., Funk, M. M., Sakamoto, F. H., Plotkin, S. R., Ly, I., Jordan, J. T., Muzikansky, A., Roberts, J., Farinelli, W. A., Levin, Y. S., et al. (2023) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2023.11.058 · Cited by 8
KRAS-targeted therapies in cancer: novel approaches and overcoming resistance
Tang, D., Kroemer, G., & Kang, R. (2025) · BMJ Oncology · doi:10.1136/bmjonc-2025-000946 · Cited by 12
“…Rac guanine nucleotide exchange factor 1 (SOS1), which promote the exchange of GDP for GTP, 16 17 and GTPase-activating proteins (GAPs), such as neurofi-bromin 1 (NF1), 18 19 which enhance the intrinsic GTPase activity of KRAS, facilitating GTP hydrolysis and returning KRAS to its inactive state.”
Molecular Characterization of Medulloblastoma in a Patient with Neurofibromatosis Type 1: Case Report and Literature Review
Ranalli, M., Boni, A., Caroleo, A. M., Baldo, G. D., Rinelli, M., Agolini, E., Rossi, S., Miele, E., Colafati, G. S., Boccuto, L., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11040647 · Cited by 8
Characterization of Immune Cell Populations of Cutaneous Neurofibromas in Neurofibromatosis 1
Kallionpää, R. A., Peltonen, S. A., Le, K. M., Martikkala, E., Jääskeläinen, M., Fazeli, E., Riihilä, P., Haapaniemi, P., Rokka, A., Salmi, M., et al. (2023) · Laboratory Investigation · doi:10.1016/j.labinv.2023.100285 · Cited by 8
Neurofibromin 1 expression is negatively correlated with malignancy and prognosis of epithelial ovarian cancer.
Qiao, G., Xuchun, J., Zhang, Y., & Chen, B. (2019) · Europe PMC (PubMed Central) · Cited by 8
Alterations in brain morphology by MRI in adults with neurofibromatosis 1
Wang, S., Mautner, V., Buchert, R., Flibotte, S., Suppa, P., Friedman, J. M., & Heran, M. K. S. (2021) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-021-02097-5 · Cited by 8
EAHP 2020 workshop proceedings, pediatric myeloid neoplasms
Leguit, R. J., Orazi, A., Kucine, N., Kvasnicka, H. M., Gianelli, U., Arber, D. A., Porwit‐MacDonald, A., & Ponzoni, M. (2022) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-022-03375-8 · Cited by 8
Genetic analysis of the catalytic domain of the GAP gene in human lung cancer cell lines
Mitsudomi, T., Friedman, E., Gejman, P. V., McCormick, F. P., & Gazdar, A. F. (1994) · Human Genetics · doi:10.1007/bf00218908 · Cited by 8
Only in Congenial Soil: The Microenvironment in Brain Tumorigenesis
Rubin, J. B. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00235.x · Cited by 8
Haploinsufficiency of the NF1 gene is associated with protection against diabetes
Kallionpää, R. A., Peltonen, S. A., Leppävirta, J., Pöyhönen, M., Auranen, K. J., Järveläinen, H., & Peltonen, J. T. K. (2020) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2020-107062 · Cited by 7
Case series of congenital pseudarthrosis of the tibia unfulfilling neurofibromatosis type 1 diagnosis: 21% with somatic NF1 haploinsufficiency in the periosteum
Yu, Z., Zhu, G., Liu, Y., Zhao, W., Yang, Y., Luo, Z., Fu, Y., Mei, H., & Hu, Z. (2022) · Human Genetics · doi:10.1007/s00439-021-02429-2 · Cited by 8
Tumor Suppressor Gene Regulation of Cell Growth: Recent Insights into Neurofibromatosis 1 and 2 Gene Function
Uhlmann, E. J., & Gutmann, D. H. (2001) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:34:1:61 · Cited by 8
“Analysis of the predicted amino acid sequence reveals a 400 amino acid region of neurofibromin with sequence homology to GAP family of proteins (79).”
Background
DLC1 is unlikely to be a primary target for deletions on chromosome arm 8p22 in head and neck squamous cell carcinoma
Hewitt, C., Wilson, P. J., McGlinn, E., Macfarlane, G. J., Papageorgiou, A., Woodwards, R. T. M., Sloan, P., Gollin, S. M., Paterson, I. C., Parkinson, K., et al. (2004) · Cancer Letters · doi:10.1016/j.canlet.2003.12.018 · Cited by 8
Mutation analysis of RASK and the ‘FLR exon’ of NF1 in sporadic ovarian carcinoma
Foulkes, W. D., Englefield, P., & Campbell, I. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90432-4 · Cited by 8
Familial cancer syndromes and genetic counseling
Tomlinson, G. E. (1997) · Cancer treatment and research · doi:10.1007/978-1-4615-5767-8_3 · Cited by 8
Renal Cell Carcinoma
Jennings, S. B., Gnarra, J. R., Walther, M. M., Zbar, B., & Linehan, W. M. (1995) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30449-6 · Cited by 8
Tumour suppressor genes and colorectal neoplasia
Koorey, D. J., & McCaughan, G. W. (1993) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1993.tb01511.x · Cited by 8
Molecular analysis of neurofibromatosis type 1 mutations
Xu, W., Yu, Q., Liu, L., Ponder, M. A., Wallace, M. R., Xu, G., & Ponder, B. A. J. (1992) · Human Mutation · doi:10.1002/humu.1380010604 · Cited by 8
“AE25 spans from nucleotides 2,5524,605, P5 spans from nucleotides 5,6257,308, and FB50 spans from nucleotides 6163,706 of the published NF1 cDNA sequence (Xu et al., 1990; Marchuk et al., 1991).”
Self-citation
Suppression of ras oncogene-mediated transformation
Schäfer, R. (2006) · Springer eBooks · doi:10.1007/bfb0031031 · Cited by 8
Bifunctional glycosphingolipid (GSL) probes to investigate GSL-interacting proteins in cell membranes
Kundu, S., Rohokale, R., Lin, C., Chen, S., Biswas, S., & Guo, Z. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100570 · Cited by 7
Familial spinal neurofibromatosis due to a multiexonic NF1 gene deletion
Pizzuti, A., Bottillo, I., Inzana, F., Lanari, V., Buttarelli, F. R., Torrente, I., Giallonardo, A. T., Luca, A. D., & Dallapiccola, B. (2011) · Neurogenetics · doi:10.1007/s10048-011-0278-5 · Cited by 7
“codes for neurofibromin [1, 2], an important negative regulator of the cellular Ras signaling pathway [3–6].”
Background
Prognostic features and comprehensive genomic analysis of NF1 mutations in EGFR mutant lung cancer patients
Tian, H., Chen, Z., Jie, G., Wang, Z., Yan, H., Wu, S.-P., Zhang, S., Lu, D., Zhang, X., & Wu, Y.-L. L. C. (2022) · Cancer Medicine · doi:10.1002/cam4.4925 · Cited by 7
Predicting IHC staining classes of NF1 using features in the hematoxylin channel
Zhang, W., Koh, M. Y., Sirohi, D., Ying, J., Brintz, B. J., & Knudsen, B. S. (2023) · Journal of Pathology Informatics · doi:10.1016/j.jpi.2023.100196 · Cited by 7
A benign form of congenital anterolateral bowing of the tibia associated with ipsilateral polydactyly of the hallux: Case report and literature review
Han, J., Qu, L., Li, Y., Luo, J., Cao, J., & Zhao, W. (2012) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35417 · Cited by 7
“Approximately, one-half of cases of NF1 are diagnosed without a known family history and are thought to represent new mutations [Xu et al., 1990; Cichowski and Jacks, 2001; Ars et al., 2003; Ferner et al., 2007].”
Background
Symptomatic epilepsy
Shorvon, S. D., Andermann, F., & Guerrini, R. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511921001.016 · Cited by 7
La neurofibromatose 1
Wolkenstein, P. (2001) · médecine/sciences · doi:10.1051/medsci/200117111158 · Cited by 7
“Ces protéines (GAP) augmentent le taux d’hydrolyse de GTP et agissent donc comme modulateur négatif de Ras [48, 49].”
Background
Qualitative Ras pathway signature for cetuximab therapy reveals resistant mechanism in colorectal cancer
Song, K., Lu, H., Jin, L., Wang, K., Guo, W., Zheng, H., Li, K., He, C., You, T., Fu, Y., et al. (2020) · FEBS Journal · doi:10.1111/febs.15306 · Cited by 7
Genetics and Epigenetics of Pancreatic Neuroendocrine Tumors and Pulmonary Carcinoids
Dreijerink, K. M. A., Derks, J. L., Cataldo, I., Scarpa, A., Valk, G. D., & Speel, E. M. (2015) · Frontiers of hormone research · doi:10.1159/000382138 · Cited by 7
Malignant peripheral nerve sheath tumor
Stawicki, S. P., Shen, Y., Hon, H., Papadimos, T. J., & Schrag, S. (2015) · International Journal of Academic Medicine · doi:10.4103/2455-5568.172704 · Cited by 7

Authors: Xu, G., O'Connell, P., Viskochil, D., Cawthon, R., Robertson, M., Culver, M., Dunn, D., Stevens, J., Gesteland, R., White, R., & Weiss, R.
Affiliations: Howard Hughes Medical Institute (US)
University of Utah (US)
ORCID: O'Connell, Peter
Viskochil, David
Cawthon, Richard
Culver, Melanie
Stevens, Jeff
Weiss, Robert
Venue: Cell
Publisher: Elsevier BV
Published: 1990-08
Volume: 62
Issue: 3
Pages: 599-608
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/0092-8674(90)90024-9
OpenAlex: W2159096148
Cited by: 1,095
References: 42
Citations by year: 2026: 7 · 2025: 13 · 2024: 19 · 2023: 19 · 2022: 22 · 2021: 22 · 2020: 22 · 2019: 18 · 2018: 22 · 2017: 17 · 2016: 19 · 2015: 21 · 2014: 24 · 2013: 24 · 2012: 45
FWCI: 70.71
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Cell (publishedVersion)
PubMed (publishedVersion)
Funders: Howard Hughes Medical Institute
U.S. Department of Energy
Topics: Health Sciences › Medicine › Clinical Neurology › Neurofibromatosis and Schwannoma Cases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Keywords: neurofibromatosis type 1, NF1 gene, GTPase-activating protein, Ras, open reading frames, cDNA cloning, cell growth regulation, protein homology
MeSH terms: Amino Acid Sequence, Animals, Base Sequence, Cattle, Chromosomes, Human, Pair 1, Chromosomes, Human, Pair 17, Cloning, Molecular, Genes, Humans, Information Systems, Molecular Sequence Data, Neurofibromatosis 1, Proteins, Sequence Homology, Nucleic Acid, Translocation, Genetic, Oligonucleotide Probes, Gene Library, Polymerase Chain Reaction, GTPase-Activating Proteins, ras GTPase-Activating Proteins, Neurofibromin 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The neurofibromatosis type 1 gene encodes a protein related to GAP

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks